Howe & Rusling’s Immunomedics Inc IMMU Stock Holding History

Howe & Rusling’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60	Closed	-$1K	–	925
2019 Q4	$1K	Buy	+60	New	+$1.06K	﹤0.01%	821

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Howe & Rusling's IMMU Position: Q1 2020 in Review

Howe & Rusling sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 60 shares — an estimated $1K sold.

Howe & Rusling first reported a position in IMMU in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

Howe & Rusling reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
Howe & Rusling sold 60 Immunomedics Inc shares in Q1 2020, an estimated $1K.
Howe & Rusling first reported a position in Immunomedics Inc in Q4 2019 and held it in 1 quarter.
Howe & Rusling's Immunomedics Inc position peaked at $1K in Q4 2019.
220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Howe & Rusling's 13F filing for Q1 2020, filed 14 May 2020.